These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12890146)

  • 1. DNA sequence profile of TP53 gene mutations in childhood B-cell non-Hodgkin's lymphomas: prognostic implications.
    Klumb CE; Furtado DR; de Resende LM; Carriço MK; Coelho AM; de Meis E; Maia RC; Rumjanek FD
    Eur J Haematol; 2003 Aug; 71(2):81-90. PubMed ID: 12890146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between mutation in P53, p53 expression, cytogenetics, histologic type, and survival in patients with B-cell non-Hodgkin's lymphoma.
    Koduru PR; Raju K; Vadmal V; Menezes G; Shah S; Susin M; Kolitz J; Broome JD
    Blood; 1997 Nov; 90(10):4078-91. PubMed ID: 9354678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic aberrations in the p53 pathway are associated with a high S phase fraction and poor patient survival in B-cell Non-Hodgkin's lymphoma.
    Stokke T; Galteland E; Holte H; Smedshammer L; Suo Z; Smeland EB; Børresen-Dale AL; DeAngelis P; Steen HB
    Int J Cancer; 2000 Jul; 89(4):313-24. PubMed ID: 10956404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and possible prognostic relevance of p53 gene mutations in diffuse large B-cell lymphoma. An analysis of 51 cases and review of the literature.
    Kerbauy FR; Colleoni GW; Saad ST; Regis Silva MR; Correa Alves A; Aguiar KC; Albuquerque DM; Kobarg J; Seixas MT; Kerbauy J
    Leuk Lymphoma; 2004 Oct; 45(10):2071-8. PubMed ID: 15370252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of p53 nuclear immunostaining is not indicative of absence of TP53 gene mutations in colorectal adenocarcinomas.
    Colomer A; Erill N; Verdú M; Roman R; Vidal A; Cordon-Cardo C; Puig X
    Appl Immunohistochem Mol Morphol; 2003 Jun; 11(2):130-7. PubMed ID: 12777996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis.
    de Anta JM; Jassem E; Rosell R; Martínez-Roca M; Jassem J; Martínez-López E; Monzó M; Sánchez-Hernández JJ; Moreno I; Sánchez-Céspedes M
    Oncogene; 1997 Dec; 15(24):2951-8. PubMed ID: 9416838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disrupted p53 function as predictor of treatment failure and poor prognosis in B- and T-cell non-Hodgkin's lymphoma.
    Møller MB; Gerdes AM; Skjødt K; Mortensen LS; Pedersen NT
    Clin Cancer Res; 1999 May; 5(5):1085-91. PubMed ID: 10353742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.
    Bouzourene H; Gervaz P; Cerottini JP; Benhattar J; Chaubert P; Saraga E; Pampallona S; Bosman FT; Givel JC
    Eur J Cancer; 2000 May; 36(8):1008-15. PubMed ID: 10885605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma.
    Ichikawa A; Kinoshita T; Watanabe T; Kato H; Nagai H; Tsushita K; Saito H; Hotta T
    N Engl J Med; 1997 Aug; 337(8):529-34. PubMed ID: 9262496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between mutations in p53 gene and protein expression in human lymphomas.
    Martinez-Delgado B; Robledo M; Arranz E; Infantes F; Echezarreta G; Marcos B; Sanz C; Rivas C; Benitez J
    Am J Hematol; 1997 May; 55(1):1-8. PubMed ID: 9136910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood.
    Pollack IF; Hamilton RL; Finkelstein SD; Campbell JW; Martinez AJ; Sherwin RN; Bozik ME; Gollin SM
    Cancer Res; 1997 Jan; 57(2):304-9. PubMed ID: 9000573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 protein expression does not correlate with EBV status in childhood B non-Hodgkin lymphomas.
    Klumb CE; Hassan R; Zalcberg IR; Resende LM; Carriço MK; Maia RC
    Pediatr Blood Cancer; 2004 Aug; 43(2):115-9. PubMed ID: 15236276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of p53, c-kit, K-ras, and beta-catenin gene in non-Hodgkin's lymphoma of adrenal gland.
    Nakatsuka S; Hongyo T; Syaifudin M; Nomura T; Shingu N; Aozasa K
    Jpn J Cancer Res; 2002 Mar; 93(3):267-74. PubMed ID: 11927008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of the p53 protein in AIDS-related non-Hodgkin's lymphomas and polymorphic lymphoproliferations.
    Martin A; Flaman JM; Frebourg T; Davi F; El Mansouri S; Amouroux J; Raphaël M
    Br J Haematol; 1998 May; 101(2):311-7. PubMed ID: 9609527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overall survival in aggressive B-cell lymphomas is dependent on the accumulation of alterations in p53, p16, and p27.
    Sánchez-Beato M; Sáez AI; Navas IC; Algara P; Sol Mateo M; Villuendas R; Camacho F; Sánchez-Aguilera A; Sánchez E; Piris MA
    Am J Pathol; 2001 Jul; 159(1):205-13. PubMed ID: 11438467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 gene mutations and rearrangements in non-Hodgkin's lymphoma.
    Chen PM; Chiou TJ; Hsieh RK; Fan FS; Chu CJ; Lin CZ; Chiang H; Yen CC; Wang WS; Liu JH
    Cancer; 1999 Feb; 85(3):718-24. PubMed ID: 10091745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.
    Møller MB; Nielsen O; Pedersen NT
    Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer.
    Berns EM; Foekens JA; Vossen R; Look MP; Devilee P; Henzen-Logmans SC; van Staveren IL; van Putten WL; Inganäs M; Meijer-van Gelder ME; Cornelisse C; Claassen CJ; Portengen H; Bakker B; Klijn JG
    Cancer Res; 2000 Apr; 60(8):2155-62. PubMed ID: 10786679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 gene analysis in childhood B non-Hodgkin's lymphoma.
    Klumb CE; de Resende LM; Tajara EH; Bertelli EC; Rumjanek VM; Maia RC
    Sao Paulo Med J; 2001 Nov; 119(6):212-5. PubMed ID: 11723536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 protein expression in non-Hodgkin's lymphomas is infrequently related to p53 gene mutations.
    Oka T; Sarker AB; Teramoto N; Yoshino T; Akagi T
    Pathol Int; 1998 Jan; 48(1):15-21. PubMed ID: 9589459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.